Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Evotec SE regarding possible recovery of investor losses under federal securities laws following the company's recent financial disclosures [1][4]. Group 1: Investigation Details - The investigation focuses on whether Evotec's executive officers complied with federal securities laws after the company announced its "Horizon" restructuring initiative [1][4]. - Evotec projected revenue for fiscal year 2026 to be approximately €700 million to €780 million and adjusted EBITDA to be approximately €0 million to €40 million, indicating a transition year [3]. - The company expects total cash restructuring charges of approximately €100 million over the 2026–2028 period, along with non-cash components related to asset impairments [3]. Group 2: Investor Information - Investors who purchased Evotec securities and suffered losses are encouraged to join the investigation, with no cost or obligation [2]. - For further information, investors can contact Jim Baker at Johnson Fistel [2].
Evotec Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses